Patents by Inventor Sebastien Holvoet

Sebastien Holvoet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION AND KIT FOR ALLEVIATING SYMPTOMS OF RESPIRATORY ALLERGY IN TODDLERS
    Publication number: 20240139264
    Abstract: The present invention relates to a composition for use in the prevention of respiratory allergy, in particular allergic rhinitis, dust mite allergy and/or asthma in toddlers. The invention also provides a kit comprising a combination of at least one polyphenol and at least one probiotic selected from the group consisting of Lactobacillus paracasei and Lactococcus lactis in one or more containers.
    Type: Application
    Filed: February 16, 2022
    Publication date: May 2, 2024
    Inventors: CARINE BLANCHARD, SEBASTIEN HOLVOET
  • COMPOSITION AND KIT FOR ALLEVIATING SYMPTOMS OF RESPIRATORY ALLERGY
    Publication number: 20240122998
    Abstract: The present invention relates to a composition for use in the prevention of respiratory allergy, in particular allergic rhinitis, dust mite allergy and/or asthma. The invention also provides a kit comprising a combination of at least one polyphenol and at least one Bifidobacterium longum in one or more containers.
    Type: Application
    Filed: February 16, 2022
    Publication date: April 18, 2024
    Inventors: CARINE BLANCHARD, FRANCINE LENFANT, ULRIKE REYMONDIN, GAELLE MARIE LAURE SCHLUP-OLLIVIER, JOYDEEP RAY, SEBASTIEN HOLVOET, CHRISTOPHE BARDE
  • NUTRITIONAL COMPOSITION
    Publication number: 20240009216
    Abstract: A nutritional composition comprising the human milk oligosaccharides (HMOs) 2?-fucosyllactose (2FL), 3?-fucosyl-lactose (3FL), 3?-sialyllactose (3SL), and lacto-N-neotetraose (LNnT). The nutritional composition is useful for treating or preventing disorders associated with an above-normal number of granulocytes in a tissue. For example, the combinations may have utility in preventing or treating eosinophilic gastrointestinal diseases.
    Type: Application
    Filed: November 9, 2021
    Publication date: January 11, 2024
    Inventors: CARINE BLANCHARD, CHEONG KWET CHOY KWONG CHUNG, SEBASTIEN HOLVOET, DOMINIQUE SANDRA DONNICOLA
  • NUTRITIONAL COMPOSITION COMPRISING HUMAN MILK OLIGOSACCHARIDES
    Publication number: 20230381211
    Abstract: A nutritional composition comprising the human milk oligosaccharides (HMOs) 2?-fucosyllactose (2FL), 3?-fucosyl-lactose (3FL), 3-sialyllactose (SSL), and lacto-N-neotetraose (LNnT). The nutritional composition is useful for inducing tolerance to an allergen, and/or speeding up outgrowth of an allergy, and/or treating or reducing the risk of an interleukin IL-10 mediated disease.
    Type: Application
    Filed: October 7, 2021
    Publication date: November 30, 2023
    Inventors: CARINE BLANCHARD, SEBASTIEN HOLVOET, DOMINIQUE SANDRA DONNICOLA, CHEONG KWET CHOY KWONG CHUNG
  • COCOA POLYPHENOLS AND SOLUBLE DIETARY FIBER FOR USE IN THE TREATMENT OR PREVENTION DISORDERS ASSOCIATED WITH AN ABOVE-NORMAL NUMBER OF GRANULOCYTES IN A TISSUE
    Publication number: 20230098752
    Abstract: The present invention relates to a composition comprising at least one cocoa polyphenol and soluble dietary fiber for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes in a tissue.
    Type: Application
    Filed: November 29, 2022
    Publication date: March 30, 2023
    Inventors: Carine Blanchard, Sebastien Holvoet, Rinat Ran-Ressler, Martinas Kuslys
  • INFANT FORMULA
    Publication number: 20230026618
    Abstract: An infant formula for use in preventing or reducing the occurrence of allergic sensitisation in an infant, wherein the infant formula comprises 0.8-2.5 g/L 2?-fucosyllactose (2?FL) and/or 0.05-0.2 g/L lacto-N-neotetraose (LNnT).
    Type: Application
    Filed: December 28, 2020
    Publication date: January 26, 2023
    Inventors: CARINE BLANCHARD, SEBASTIEN HOLVOET
  • Cocoa polyphenols and soluble dietary fiber for use in the treatment or prevention disorders associated with an above-normal number of granulocytes in a tissue
    Patent number: 11541031
    Abstract: The present invention relates to a composition comprising at least one cocoa polyphenol and soluble dietary fiber for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes in a tissue.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: January 3, 2023
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Carine Blanchard, Sebastien Holvoet, Rinat Ran-Ressler, Martinas Kuslys
  • Plant phenols and their use in the treatment or prevention of eosinophilic esophagitis
    Patent number: 11382891
    Abstract: Plant phenols, in particular, plant phenolic acids, like rosemarinic acid, ellagic acid, and chlorogenic acid, can be used in the treatment or prevention of eosinophilic esophagitis.
    Type: Grant
    Filed: January 2, 2020
    Date of Patent: July 12, 2022
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Carine Blanchard, Sebastien Holvoet
  • COMPOSITION FOR PREVENTING OR REDUCING TRANSEPIDERMAL WATER LOSS AND IMPROVING SKIN BARRIER FUNCTION
    Publication number: 20220062161
    Abstract: The present invention relates to the use of a milk whey protein hydrolysate for preventing or treating transepidermal water loss (TEWL) and/or TEWL-associated disorders or/and enhancing skin barrier function in young and adult mammals. The protein hydrolysate may be used in the prevention or treatment of TEWL-associated disorders, such as atopic dermatitis, dry or reactive skin or skin dehydration. It may also be used in the cosmetic use of improving skin appearance.
    Type: Application
    Filed: December 18, 2019
    Publication date: March 3, 2022
    Inventors: Carine Blanchard, Sebastien Holvoet
  • PLANT PHENOLS AND THEIR USE IN THE TREATMENT OR PREVENTION OF EOSINOPHILIC ESOPHAGITIS
    Publication number: 20200222363
    Abstract: Plant phenols, in particular, plant phenolic acids, like rosemarinic acid, ellagic acid, and chlorogenic acid, can be used in the treatment or prevention of eosinophilic esophagitis.
    Type: Application
    Filed: January 2, 2020
    Publication date: July 16, 2020
    Inventors: Carine Blanchard, Sebastien Holvoet
  • Plant phenols and their use in the treatment or prevention of eosinophilic esophagitis
    Patent number: 10548873
    Abstract: Plant phenols, in particular, plant phenolic acids, like rosmarinic acid, ellagic acid, and chlorogenic acid, are used in the treatment or prevention of eosinophilic esophagitis.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: February 4, 2020
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Carine Blanchard, Sebastien Holvoet
  • Composition comprising plant phenols for preventing or reducing TEWL and associated disorders and diseases
    Patent number: 10500187
    Abstract: Plant phenols, in particular, plant phenolic acids, like rosmarinic acid, ellagic acid, and chlorogenic acid, are used in preventing or reducing transepidermal water loss (TEWL) and associated disorders and diseases.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: December 10, 2019
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Carine Blanchard, Marjorie Guitard, Sebastien Holvoet
  • Cocoa polyphenols and their use in the treatment or prevention of eosinophilic esophagitis
    Patent number: 10350252
    Abstract: The present invention relates to the use of cocoa polyphenols, in particular, procyanidin(s) in the treatment or prevention of eosinophilic esophagitis.
    Type: Grant
    Filed: September 22, 2014
    Date of Patent: July 16, 2019
    Assignee: Nestec S.A.
    Inventors: Carine Blanchard, Sebastien Holvoet
  • COCOA POLYPHENOLS AND SOLUBLE DIETARY FIBER FOR USE IN THE TREATMENT OR PREVENTION DISORDERS ASSOCIATED WITH AN ABOVE-NORMAL NUMBER OF GRANULOCYTES IN A TISSUE
    Publication number: 20190008824
    Abstract: The present invention relates to a composition comprising at least one cocoa polyphenol and soluble dietary fiber for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes in a tissue.
    Type: Application
    Filed: December 1, 2016
    Publication date: January 10, 2019
    Inventors: Carine Blanchard, Sebastien Holvoet, Rinat Ran-Ressler, Martinas Kuslys
  • Epicatechin for alleviating symptoms of allergy
    Patent number: 9907781
    Abstract: The present invention relates to epicatechin for use in the prevention or reduction of symptoms of an allergic disorder and/or an allergic reaction. The invention further relates to epicatechin for said use in the form of food, food product, food supplement or pharmaceutical products.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: March 6, 2018
    Assignee: Nestec S.A.
    Inventors: Annick Mercenier, Anurag Singh, Sebastien Holvoet, Fabiola Dionisi, Lucas Actis Goretta
  • Composition comprising specific strains and reducing food and/or respiratory allergy symptoms
    Patent number: 9839656
    Abstract: A composition comprising specific Lactobacillus helveticus strains is provided for reducing the symptoms of allergies originating from food, respiratory or contact allergens. Preferably the composition reduces symptoms of allergies (secondary prevention) while also able to reduce sensitization (primary prevention).
    Type: Grant
    Filed: January 16, 2013
    Date of Patent: December 12, 2017
    Assignee: Nestec S.A.
    Inventors: Sebastien Holvoet, Annick Mercenier, Marietta Weiss, Adrian Walter Zuercher
  • Nutritional composition comprising strains and reducing food allergy symptoms, especially in infants and children
    Patent number: 9439449
    Abstract: A complete nutritional composition comprising Bifidobacterium strains or probiotic is provided for reducing the symptoms of allergies originating from food allergens in young children or infants. Preferably the composition reduces symptoms of allergies (secondary prevention) and also reduces sensitization (primary prevention). The composition comprises a probiotic of the genus Bifidobacterium.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: September 13, 2016
    Assignee: Nestec S.A.
    Inventors: Sebastien Holvoet, Annick Mercenier, Adrian Zuercher
  • COCOA POLYPHENOLS AND THEIR USE IN THE TREATMENT OR PREVENTION OF EOSINOPHILIC ESOPHAGITIS
    Publication number: 20160213721
    Abstract: The present invention relates to the use of cocoa polyphenols, in particular, procyanidin(s) in the treatment or prevention of eosinophilic esophagitis.
    Type: Application
    Filed: September 22, 2014
    Publication date: July 28, 2016
    Inventors: Carine Blanchard, Sebastien Holvoet
  • COMPOSITION COMPRISING PLANT PHENOLS FOR PREVENTING OR REDUCING TEWL AND ASSOCIATED DISORDERS AND DISEASES
    Publication number: 20150238462
    Abstract: The present invention relates to the use of plant phenols, in particular, plant phenolic acids, like rosemarinic acid, ellagic acid, and chlorogenic acid in preventing or reducing transepidermal water loss (TEWL) and associated disorders and diseases.
    Type: Application
    Filed: September 12, 2013
    Publication date: August 27, 2015
    Inventors: Carine Blanchard, Marjorie Guitard, Sebastien Holvoet
  • PLANT PHENOLS AND THEIR USE IN THE TREATMENT OR PREVENTION OF EOSINOPHILIC ESOPHAGITIS
    Publication number: 20150238461
    Abstract: The present invention relates to the use of plant phenols, in particular, plant phenolic acids, like rosemarinic acid, ellagic acid, and chlorogenic acid in the treatment or prevention of eosinophilic esophagitis.
    Type: Application
    Filed: September 23, 2013
    Publication date: August 27, 2015
    Inventors: Carine Blanchard, Sebastien Holvoet